Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1

Neuroscience Letters

Volumn 414, Issue 2, 2007, Pages 130-135

  Umahara, Takahiko ^a,b   Uchihara, Toshiki ^b   Yagishita, Saburo ^c   Nakamura, Ayako ^b   Tsuchiya, Kuniaki ^d   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c KANAGAWA REHABILITATION CENTER   (Japan)

^d TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

Author keywords

14 3 3 proteins; Ataxin 1; Neuronal intranuclear inclusion; Polyglutamine disease; Spinocerebellar ataxia type 1

Indexed keywords

ATAXIN 1; PROTEIN 14 3 3;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN; CASE REPORT; CEREBELLUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN TISSUE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PONS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SPINOCEREBELLAR DEGENERATION;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN; CELL NUCLEUS; CEREBELLAR NUCLEI; CEREBELLUM; HUMANS; IMMUNOHISTOCHEMISTRY; INTRANUCLEAR INCLUSION BODIES; MIDDLE AGED; NEURONS; PEPTIDES; PONS; PROTEIN ISOFORMS; PURKINJE CELLS; SPINOCEREBELLAR ATAXIAS; UP-REGULATION;

EID: 33847064609     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.12.026     Document Type: Article

References (21)

1. Aitken A. 14-3-3 proteins: a historic overview. Semin. Cancer Biol. 16 (2006) 162-172
2. Aitken A., Colling D.B., van Heusden B.P., Isobe T., Roseboon P.H., Rosenfeld G., and Soll J. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem. Sci. 17 (1992) 498-501
3. Berg D., Holzmann C., and Riess O. 14-3-3 proteins in the nervous system. Nat. Rev. Neurosci. 4 (2003) 752-762
4. Brunet A., Kanai F., Stehn J., Stehn J., Xu J., Sarbassova D., Frangioni J.V., Dalal S.N., DeCaprio J.A., Greenberg M.E., and Yaffe M.B. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156 (2002) 817-828
5. Chen H.-K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandes M.H., Aitken A., Skoulakis E.M.C., Orr H.T., Botas J., and Zoghbi HY H.Y. Interaction of Akt-phosphorylated Ataxin-1 with 14-3-3 mediates neurodegeration in spinocerebellar ataxia type. Cell 113 (2003) 457-468
6. Dougherty M.K., and Morrison D.K. Unlocking the code of 14-3-3. J. Cell Sci. 117 (2004) 1875-1884
7. Emamian E.S., Kaytor M.D., Duvic L.A., Tousey S.K., Zoghbi H.Y., Clark H.B., and Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA 1 transgenic mice. Neuron 38 (2003) 375-387
8. Grozinger C.M., and Schreiber S.L. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. 97 (2000) 7835-7840
9. Heintz N. Ataxin-1 regulators in the spotlight. Science 301 (2003) 59-60
10. Koyano S., Iwabuchi K., Yagishita S., Kuroiwa Y., and Uchihara T. Paradoxical absence of nuclear inclusion in cerebellar Purkinje cells of hereditary ataxias linked to CAG expansion. J. Neurol. Neurosurg. Psychiatry 73 (2002) 450-452
11. Mhawech P. 14-3-3 proteins-an update. Cell Res. 15 (2005) 228-236
12. Pan S., Sehnke P.S., Ferl R.J., and Gurley W.B. Specific interactions with TBP and TFIIB in vitro suggest that 14-3-3 proteins may participate in the regulation of transcription when part of a DNA binding complex. Plant Cell 11 (1999) 1591-1602
13. Shimohata T., Nakajima T., Yamada M., Uchida C., Onodera O., Naruse S., Kimura T., Koide R., Nozaki K., Sano Y., Ishiguro H., Sakoe K., Ooshima T., Sato A., Ikeuchi T., Oyake M., Sato T., Aoyagi Y., Hozumi I., Nagaysu T., Takiyama Y., Nishizawa M., Goto J., Kanazawa I., Davidson I., Takahashi H., and Tsuji S. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent cellular localization. Nat. Genet. 26 (2000) 29-36
14. Trottier Y., Lutz Y., Stevanin G., Imbert G., Derys D., Cancel G., Saudou F., and Weber C. Polyglutamine expansion as a prthological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378 (1995) 403-406
15. Tzivion G., and Avruch J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 14 (2001) 3061-3064
16. Umahara T., Uchihara T., Tsuchiya K., Nakamura A., Ikeda K., Iwamoto T., and Takasaki M. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol. 108 (2004) 279-286
17. Umahara T., Uchihara T., Tsuchiya K., Nakamura A., Ikeda K., Iwamoto T., and Takasaki M. Immunolocalization of 14-3-3 isoforms in brains with Pick body disease. Neurosci. Lett. 371 (2004) 215-219
18. van Hemert M.J., Niemantsverdriet M., Schmidt T., Backendorf C., and Spaink H.P. Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3 sigma and 14-3-3 zeta. J. Cell Sci. 117 (2004) 1411-1420
19. Wakabayashi H., Yano M., Tachikawa N., Oka S., Maeda M., and Kido H. Increased concentration of 14-3-3 epsilon, gamma, and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction. Clin. Chim. Acta 312 (2001) 97-105
20. Yamada M., Mood J.M., Shimohata T., Hayashi S., Tsuji S., Ross C.R., and Takahashi H. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentrorubral-pallidoluysian atrophy. Ann. Neurol. 49 (2001) 14-23
21. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619-692